Recent advances have been made in therapeutic gene-editing technologies, with developments in crisper base editing, genome engineering, and gene therapy. These advancements have potential applications in treating various diseases, including hematological disorders. The technology is being explored and applied in clinical settings, with some institutions reportedly using personalized crispr gene editing therapy to treat patients.